SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001171843-20-004805
Filing Date
2020-07-07
Accepted
2020-07-07 16:32:12
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 f424b5_070720.htm 424B5 246449
2 GRAPHIC logo.jpg GRAPHIC 5755
  Complete submission text file 0001171843-20-004805.txt   255476
Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 424B5 | Act: 33 | File No.: 333-239538 | Film No.: 201016391
SIC: 2834 Pharmaceutical Preparations